Is Forte Biosciences FBRX stock respecting technical levels Q4 2025 Earnings Fall Short LECO Lincoln posts small Q4 2025 EPS beat shares edge down 12 on cautious investor sentiment Biogen Inc BIIB Secures Felzartamab Rights to Challenge Darzalex Dominance in Chinas Multiple Myeloma Market